Literature DB >> 28498909

Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology.

Cira Dansokho1,2, Pierre Aucouturier1,2, Guillaume Dorothée1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28498909     DOI： 10.1093/brain/awx108

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  2 in total

Review 1.  The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's Disease.

Authors:  Lucrezia Cellai; Kevin Carvalho; Emilie Faivre; Aude Deleau; Didier Vieau; Luc Buée; David Blum; Céline Mériaux; Victoria Gomez-Murcia
Journal:  Front Neurosci       Date:  2018-08-03       Impact factor: 4.677

2.  Increased prefrontal cortex interleukin-2 protein levels and shift in the peripheral T cell population in progressive supranuclear palsy patients.

Authors:  Rasmus Rydbirk; Betina Elfving; Jonas Folke; Bente Pakkenberg; Kristian Winge; Tomasz Brudek; Susana Aznar
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.